| Income Statement |
| Total Revenue | 69.59M |
|
| Revenues (USD) | 69.59M |
| Cost of Revenue | 16.67M |
| Gross Profit | 52.91M |
| Operating Expenses | 51.04M |
| Research and Development Expense | 29.24M |
| Selling, General and Administrative Expense | 20.54M |
| Operating Income | 1.88M |
| Interest Expense | 1.45M |
| Income Tax Expense | 15.00K |
| Net Income | 1.53M |
| Net Income Common Stock | 1.53M |
| Net Income Common Stock (USD) | 1.53M |
| Consolidated Income | 1.53M |
| Earnings per Basic Share | 0.03 |
| Earnings per Basic Share (USD) | 0.03 |
| Earnings per Diluted Share | 0.03 |
| Earning Before Interest & Taxes (EBIT) | 3.00M |
| Earning Before Interest & Taxes (USD) | 3.00M |
| Weighted Average Shares | 45.18M |
| Weighted Average Shares Diluted | 47.74M |
| Balance Sheet |
| Cash and Equivalents | 127.61M |
| Cash and Equivalents (USD) | 127.61M |
| Trade and Non-Trade Receivables | 45.90M |
| Current Assets | 212.26M |
| Property, Plant & Equipment Net | 43.83M |
| Total Assets | 620.94M |
| Debt Current | 4.06M |
| Total Debt | 187.05M |
| Current Liabilities | 101.94M |
| Debt Non-Current | 183.00M |
| Total Liabilities | 454.58M |
| Accumulated Retained Earnings (Deficit) | -942.49M |
| Accumulated Other Comprehensive Income | -27.88M |
| Shareholders Equity | 166.35M |
| Shareholders Equity (USD) | 166.35M |
| Assets Non-Current | 408.68M |
| Total Debt (USD) | 187.05M |
| Deferred Revenue | 198.21M |
| Goodwill and Intangible Assets | 295.98M |
| Liabilities Non-Current | 352.65M |
| Trade and Non-Trade Payables | 2.69M |
| Tax Assets | 38.71M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 2.85M |
| Net Cash Flow from Financing | -1000 |
| Net Cash Flow / Change in Cash & Cash Equivalents | 19.35M |
| Capital Expenditure | -340.00K |
| Issuance (Purchase) of Equity Shares | -1000 |
| Net Cash Flow from Investing | -397.00K |
| Net Cash Flow from Operations | 19.96M |
| Effect of Exchange Rate Changes on Cash | -215.00K |
| Share Based Compensation | 7.52M |